IRVINE, Calif., April 10, 2018 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter ended March 31, 2018 after the market closes on Tuesday, April 24, 2018, and will host a conference call at 5:00 p.m. […]
Other News
Recently Published CARRESS-HF Per Protocol Analysis Demonstrates Greater Fluid Reduction in Heart Failure Patients Using CHF Solutions’ Aquadex FlexFlow System
EDEN PRAIRIE, Minn., April 10, 2018 (GLOBE NEWSWIRE) — A recently published study in the European Journal of Heart Failure highlighted a per protocol analysis of the CARRESS-HF study, which demonstrated that ultrafiltration with the Aquadex Flex Flow System by CHF Solutions, Inc. (Nasdaq:CHFS) was associated with a higher cumulative fluid loss (p=0.003), […]
NobleStitch™ EL Italian Registry Data Published In EuroIntervention
ROME, April 9, 2018 /PRNewswire/ — Nobles Medical Technologies II, Inc. (NMT2) has announced the first peer-reviewed publication of data for PFO closure using the NobleStitch™ EL. The first systematic clinical experience by using the revolutionary “deviceless” technique to close Patent Foramen Ovale (PFO) has been recently published in the prestigious peer-reviewed European […]
Key Findings of the Global Prosthetic Heart Valves Market | Technavio
LONDON–(BUSINESS WIRE)–The latest market research report by Technavio on the global prosthetic heart valves market predicts a CAGR of above 12% during the period 2018-2022. The report segments the global prosthetic heart valves market by product (transcatheter heart valves, tissue heart valves, and mechanical heart valves), by end-user (hospitals and ASCs), and by geography (the Americas, EMEA, and […]
HeartSciences Showcases MyoVista® Wavelet ECG at 2018 China International Medicinal Equipment Fair (CMEF)
SOUTHLAKE, Texas–(BUSINESS WIRE)–HeartSciences, an innovative medical device company, is proud to announce its participation as an exhibitor at the upcoming 2018 China International Medicinal Equipment Fair (CMEF) Shanghai, China, April 11-14, 2018. CMEF has become the largest fair of medical devices, related products and services in the Asia-Pacific region. The […]
Angiograms and Angioplasty – Using your body’s vascular highway to identify and treat blockages
CHICAGO, April 9, 2018 /PRNewswire-USNewswire/ — Has your doctor prescribed an angiogram? If you are not sure what to expect, you’re not alone. The Society for Vascular Surgery angiogram information web page is the number one most-visited of all its patient information pages. What does a vascular surgeon do? In fact, says vascular […]
Phase III CardiAMP Heart Failure Trial Featured in American Heart Journal
SAN CARLOS, Calif., April 9, 2018 /PRNewswire/ — BioCardia®, Inc., [OTC: BCDA] a leader in cardiovascular regenerative medicine, today announced the publication of the Phase III CardiAMP Heart Failure Trial design paper in the American Heart Journal. Titled “The CardiAMP Heart Failure Trial: A Randomized Controlled Pivotal Trial of High Dose Autologous Bone […]
Cardiac Monitoring and Cardiac Rhythm Management Devices Market Worth USD 25.12 Billion by 2022
PUNE, India, April 9, 2018 /PRNewswire/ — According to a new market research report “Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Product (ECG, Cardiac Output Monitoring, ILR), CRM [ICDs, External Defibrillator, Pacemaker (Dual Chamber Pacemaker)], End User (Home and Ambulatory, Hospital) – Global Forecast to 2022“, published by MarketsandMarkets™, the market is […]
Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension
DUBLIN – April 9, 2018 – Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval to begin an investigational device exemption (IDE) pivotal trial to evaluate the Symplicity Spyral(TM) renal denervation system in patients with high blood pressure (hypertension). Renal denervation is a minimally invasive procedure intended […]
Fischer Medical Receives U.S. FDA 510(k) Clearance to Market Bloom2 Cardiac Stimulator
DENVER, April 9, 2018 /PRNewswire/ — Fischer Medical has announced that the Bloom2 cardiac electrophysiology stimulator device has received U.S. Food and Drug Administration (FDA) 510(k) clearance. The Bloom2stimulator is a fundamental component of nearly all electrophysiology (EP) procedures to diagnose and treat cardiac rhythm disorders. The release of the digital version of […]
Recent
CorVascular to Showcase DuplexABI™ Solution at SVU 2026 Annual Conference & Marketplace
VDyne Announces First Patient Treated in TRIVITA US IDE Pivotal Study of the TriNovaTM Transcatheter Tricuspid Valve Replacement System
HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results
Popular
- No commented posts yet